Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1: Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities

References

1. ↵
   Riccardi VM. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 2nd ed. Baltimore: Johns Hopkins University Press; 1992
2. Gutmann DH. Recent insights into neurofibromatosis type 1: clear genetic progress. Arch Neurol 1998;55:778-780

   CrossRefPubMedWeb of Science
3. ↵
   Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 1992;356:713-715

   CrossRefPubMedWeb of Science
4. ↵
   Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997;70:138-143

   CrossRefPubMedWeb of Science
5. ↵
   Van Es S, North KN, McHugh K, Silva MD. MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 1996;26:478-487

   CrossRefPubMedWeb of Science
6. ↵
   Giordano MJ, Mahadeo DK, He YY, Geist RT, Hsu C, Gutmann DH. Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res 1996;43:246-253

   CrossRefPubMedWeb of Science
7. ↵
   Gutmann DH, Zhang Y, Hirbe A. Developmental dysregulation of a neuron-specific neurofibromatosis 1 isoform. Ann Neurol 1999;46:777-782

   CrossRefPubMedWeb of Science
8. ↵
   Said SM, Yeh TL, Greenwood RS, Whitt JK, Tupler LA, Krishnan KR. MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis. Neuroreport 1996;7:1941-1944

   PubMedWeb of Science
9. ↵
   Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-1668

   Abstract/FREE Full Text
10. ↵
    Denckla MB, Hofman K, Mazzocco MM, et al. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 1996;67:98-102

    CrossRefPubMedWeb of Science
11. Ferner RE, Hughes RA, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 1996;138:125-133

    CrossRefPubMed
12. North K, Joy P, Yuille D, et al. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 1994;44:878-883

    Abstract/FREE Full Text
13. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-378

    Abstract/FREE Full Text
14. ↵
    Aoki S, Barkovich AJ, Nishimura K, et al. Neurofibromatosis types 1 and 2: cranial MR findings. Radiology 1989;172:527-534

    PubMedWeb of Science
15. Sevick RJ, Barkovich AJ, Edwards MS, Koch T, Berg B, Lempert T. Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR Am J Roentgenol 1992;159:171-175

    PubMedWeb of Science
16. Ferner RE, Chaudhuri R, Bingham J, Cox T, Hughes RA. MRI in neurofibromatosis 1: the nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993;56:492-495

    Abstract/FREE Full Text
17. Itoh T, Magnaldi S, White RM, et al. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 1994;15:1513-1519

    Abstract/FREE Full Text
18. Parazzini C, Triulzi F, Bianchini E, et al. Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation. AJNR Am J Neuroradiol 1995;16:1711-1718

    Abstract
19. Terada H, Barkovich AJ, Edwards MS, Ciricillo SM. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1. AJNR Am J Neuroradiol 1996;17:755-760

    Abstract
20. DiMario FJ Jr, Ramsby G. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1. Arch Neurol 1998;55:500-505

    CrossRefPubMedWeb of Science
21. ↵
    Moore BD, Slopis JM, Jackson EF, De Winter AE, Leeds NE. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 2000;54:914-920

    Abstract/FREE Full Text
22. ↵
    Steen RG, Gronemeyer SA, Kingsley PB, Reddick WE, Langston JW, Taylor JS. Precise and accurate measurement of proton T1 in human brain in vivo: validation and preliminary clinical application. J Magn Reson Imaging 1994;4:681-691

    PubMedWeb of Science
23. ↵
    Steen RG, Gronemeyer SA, Taylor JS. Age-related changes in proton T1 values of normal human brain. J Magn Reson Imaging 1995;5:43-48

    PubMed
24. ↵
    Steen RG, Ogg RJ, Reddick WE, Kingsley PB. Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence. AJNR Am J Neuroradiol 1997;18:819-828

    Abstract/FREE Full Text
25. Cho S, Jones D, Reddick WE, Ogg RJ, Steen RG. Establishing norms for age-related changes in proton T1 of human brain tissue in vivo. Magn Reson Imaging 1997;15:1133-1143

    CrossRefPubMedWeb of Science
26. ↵
    Steen RG, Reddick WE, Mulhern RK, et al. Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI. J Magn Reson Imaging 1998;8:535-543

    PubMedWeb of Science
27. Steen RG, Xiong X, Mulhern RK, Langston JW, Wang WC. Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol 1999;45:279-286

    CrossRefPubMedWeb of Science
28. ↵
    National Institutes of Health Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol 1988;45:575-578

    CrossRefPubMedWeb of Science
29. ↵
    Jones KL. Recognizable Patterns of Human Malformation. 5th ed. Philadelphia: Saunders; 1997
30. ↵
    Wechsler D. Wechsler Intelligence Scale for Children.. 3rd ed. San Antonio, TX: The Psychological Corp; 1991
31. Cawthon RM, Weiss R, Xu GF, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193-201

    CrossRefPubMedWeb of Science
32. ↵
    Broniscer A, Gajjar A, Bhargava R, et al. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 1997;40:331-337

    CrossRefPubMedWeb of Science
33. ↵
    Raininko R, Autti T, Vanhanen SL, Ylikoski A, Erkinjuntti T, Santavuori P. The normal brain stem from infancy to old age: a morphometric MRI study. Neuroradiology 1994;36:364-368

    CrossRefPubMedWeb of Science
34. ↵
    Rakic P, Yakovlev PI. Development of the corpus callosum and cavum septi in man. J Comp Neurol 1968;132:45-72

    CrossRefPubMedWeb of Science
35. ↵
    Hayakawa K, Konishi Y, Matsuda T, et al. Development and aging of brain midline structures: assessment with MR imaging. Radiology 1989;172:171-177

    PubMedWeb of Science
36. ↵
    Steen RG, Reddick WE, Ogg RJ. More than meets the eye: significant regional heterogeneity in human cortical T1. Magn Reson Imaging 2000;18:361-368
37. ↵
    Reddick WE, Ogg RJ, Steen RG, Taylor JS. Statistical error mapping for reliable quantitative T1 imaging. J Magn Reson Imaging 1996;6:244-249

    CrossRefPubMed
38. Kingsley PB, Ogg RJ, Reddick WE, Steen RG. Correction of errors caused by imperfect inversion pulses in MR imaging measurement of T1 relaxation times. Magn Reson Imaging 1998;16:1049-1055

    CrossRefPubMed
39. ↵
    Glass JO, Reddick WE, Goloubeva O, Yo V, Steen RG. Hybrid artificial neural network segmentation of precise and accurate inversion recovery (PAIR) images from normal brain. Magn Reson Imaging 2000;18:1245-1253

    CrossRefPubMed
40. ↵
    Reddick WE, Glass JO, Cook EN, Elkin TD, Deaton RJ. Automated segmentation and classification of multispectral magnetic resonance images of brain using artificial neural networks. IEEE Trans Med Imaging 1997;16:911-918

    CrossRefPubMedWeb of Science
41. Reddick WE, Mulhern RK, Elkin TD, Glass JO, Merchant TE, Langston JW. A hybrid neural network analysis of subtle brain volume differences in children surviving brain tumors. Magn Reson Imaging 1998;16:413-421

    CrossRefPubMedWeb of Science
42. ↵
    Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999;89:45-52

    CrossRefPubMedWeb of Science
43. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain 1988;111:1355-1381

    Abstract/FREE Full Text
44. Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Mason G, Cheung S. Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 1999;104:e49

    Abstract/FREE Full Text
45. Eldridge R, Denckla MB, Bien E, et al. Neurofibromatosis type 1 (Recklinghausen's disease): neurologic and cognitive assessment with sibling controls. Am J Dis Child 1989;143:833-837

    CrossRefPubMed
46. Cnossen MH, Moons KG, Garssen MP, et al. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. J Med Genet 1998;35:624-627

    Abstract/FREE Full Text
47. Zvulunov A, Weitz R, Metzker A. Neurofibromatosis type 1 in childhood: evaluation of clinical and epidemiologic features as predictive factors for severity. Clin Pediatr 1998;37:295-299

    Abstract/FREE Full Text
48. ↵
    Kaplan AM, Chen K, Lawson MA, Wodrich DL, Bonstelle CT, Reiman EM. Positron emission tomography in children with neurofibromatosis-1. J Child Neurol 1997;12:499-506

    Abstract/FREE Full Text
49. ↵
    Wang PY, Kaufmann WE, Koth CW, Denckla MB, Barker PB. Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging. Ann Neurol 2000;47:477-484

    CrossRefPubMedWeb of Science